Source: Libertarian Institute
by Roman Gelperin
“In early 2024, Rick Doblin — the man whose work launched one of the biggest social and cultural movements of our time, ‘the Psychedelic Renaissance’ — was expecting to see the crowning achievement of his life’s mission. The non-profit he led and founded, the Multidisciplinary Association for Psychedelic Studies (MAPS), had recently published the second of its Phase 3 clinical trials of the psychedelic drug MDMA, investigating its efficacy in the treatment of Post-Traumatic Stress Disorder (PTSD). The results seemed incontestable. … And then, in August 2024, ‘the FDA decision was worse than any of us [had] anticipated,’ said Doblin. It outright rejected the New Drug Application for MDMA, demanding that MAPS conduct a third Phase 3 study to gather more information, a process that would require at least three more years.” (01/07/26)
https://libertarianinstitute.org/articles/the-psychedelic-renaissance-continues